Title : ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib.

Pub. Date : 2019 Aug 5

PMID : 31382924






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
3 The ALK inhibitor (crizotinib) exhibits therapeutic effect against ROS1-rearranged NSCLC. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens